Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Coagulation and fibronolysis

Citations 1-10 of 139 total displayed.

Most recent content (3 Jun 2008):

Correspondence
Response to Letters Regarding Article "Aprotinin Does Not Increase the Risk of Renal Failure in Cardiac Surgery Patients"
Anthony P. Furnary, Gary L. Grunkemeier, YingXing Wu, Loren Hiratska, and U. Scott Page, III
Circulation 2008; 117: e476, doi:10.1161/CIRCULATIONAHA.107.756478 [Full text]  

Past content (since Jan 1999):

Imaging
Technetium 99m–Labeled Annexin V Scintigraphy of Platelet Activation in Vegetations of Experimental Endocarditis
Francois Rouzet, Miguel Dominguez Hernandez, Florence Hervatin, Laure Sarda-Mantel, Agnes Lefort, Xavier Duval, Liliane Louedec, Bruno Fantin, Dominique Le Guludec, and Jean-Baptiste Michel
Circulation 117: 781 -789; published online before print as doi:10.1161/CIRCULATIONAHA.107.718114 [Abstract] [Full text]  

Articles
Technetium 99m–Labeled Annexin V Scintigraphy of Platelet Activation in Vegetations of Experimental Endocarditis
Francois Rouzet, Miguel Dominguez Hernandez, Florence Hervatin, Laure Sarda-Mantel, Agnes Lefort, Xavier Duval, Liliane Louedec, Bruno Fantin, Dominique Le Guludec, and Jean-Baptiste Michel
Circulation published January 28, 2008, doi:10.1161/CIRCULATIONAHA.107.718114 [Abstract]  

Epidemiology
Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke: The Edinburgh Artery Study
Ioanna Tzoulaki, Gordon D. Murray, Amanda J. Lee, Ann Rumley, Gordon D.O. Lowe, and F. Gerald R. Fowkes
Circulation 115: 2119 -2127; published online before print as doi:10.1161/CIRCULATIONAHA.106.635029 [Abstract] [Full text]  

Articles
Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke. The Edinburgh Artery Study
Ioanna Tzoulaki, Gordon D. Murray, Amanda J. Lee, Ann Rumley, Gordon D.O. Lowe, and F. Gerald R. Fowkes
Circulation published April 2, 2007, doi:10.1161/CIRCULATIONAHA.106.635029 [Abstract]  

Editorials
The Scientific Community’s Quest to Identify Optimal Targets for Anticoagulant Pharmacotherapy
Kenneth W. Mahaffey and Richard C. Becker
Circulation 2006; 114: 2313-2316, doi:10.1161/CIRCULATIONAHA.106.664169 [Full text]  

Epidemiology
Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study
Ann Smith, Chris Patterson, John Yarnell, Ann Rumley, Yoav Ben-Shlomo, and Gordon Lowe
Circulation 2005; 112: 3080-3087, doi:10.1161/CIRCULATIONAHA.105.557132 [Abstract] [Full text]  

Epidemiology
Comprehensive Survey of Common Genetic Variation at the Plasminogen Activator Inhibitor-1 Locus and Relations to Circulating Plasminogen Activator Inhibitor-1 Levels
Sekar Kathiresan, Stacey B. Gabriel, Qiong Yang, Amy L. Lochner, Martin G. Larson, Daniel Levy, Geoffrey H. Tofler, Joel N. Hirschhorn, and Christopher J. O’Donnell
Circulation 2005; 112: 1728-1735, doi:10.1161/CIRCULATIONAHA.105.547836 [Abstract] [Full text]  

Basic Science for Clinicians
Pathophysiology of Coronary Artery Disease
Peter Libby and Pierre Theroux
Circulation 2005; 111: 3481-3488, doi:10.1161/CIRCULATIONAHA.105.537878 [Abstract] [Full text]  

Images in Cardiovascular Medicine
Free-Floating Thrombus in Right Heart and Massive Pulmonary Embolism Migrating Into Pulmonary Artery
Yoshihiro Noji, Tohru Kojima, Takahiko Aoyama, Masato Yamaguchi, Tsutomu Araki, Susumu Fujino, Katsuaki Yokota, Noriko Kumamoto, Takakiyo Nakaya, Keiichiro Takase, Masami Shimizu, and Hiroshi Mabuchi
Circulation 2005; 111: e438-439e, doi:10.1161/CIRCULATIONAHA.104.491340 [Full text]  

[Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

* Subspecialty Collections Home

* Show  Coagulation and fibronolysis
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors